AIDS Group Accuses Glaxo of $2.2 Million in 340B Overcharges

by Admin | September 13, 2013 2:36 pm

September 13, 2013 –AIDS Healthcare Foundation (AHF) has filed suit[1] against drug manufacturer GlaxoSmithKline (GSK) claiming that the drug maker violated California law when it reportedly declined to credit AHF for alleged overpayments exceeding $2 million over nine years on 340B covered outpatient drugs. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. filed suit: http://www.aidshealth.org/wp-content/uploads/2013/06/Complaint.pdf
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/09/aids-group-accuses-glaxo-of-2-2-million-in-340b-overcharges/

Copyright ©2024 340binformed.org unless otherwise noted.